Granules India spurts after USFDA approval for generic – Business Standard


Moneycontrol.com

Granules India spurts after USFDA approval for generic
Business Standard
Granules India rose 9.35% to Rs 105.80 at 11:05 IST on BSE after the company said that it received US drug regulator's approval for generic Methylergonovine tablets. The announcement was made before trading hours today, 17 May 2018. Meanwhile, the ...
Market Live: Sensex falls 100 pts as Brent crude inches up towards $80/bblMoneycontrol.com
Granules India surges 9% on drug approvalIndiainfoline

all 11 news articles »